AT339901B - Verfahren zur herstellung von neuen tetrazolderivaten - Google Patents

Verfahren zur herstellung von neuen tetrazolderivaten

Info

Publication number
AT339901B
AT339901B AT157174A AT157174A AT339901B AT 339901 B AT339901 B AT 339901B AT 157174 A AT157174 A AT 157174A AT 157174 A AT157174 A AT 157174A AT 339901 B AT339901 B AT 339901B
Authority
AT
Austria
Prior art keywords
producing new
tetrazole derivatives
new tetrazole
derivatives
producing
Prior art date
Application number
AT157174A
Other languages
English (en)
Other versions
ATA157174A (de
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ATA157174A publication Critical patent/ATA157174A/de
Application granted granted Critical
Publication of AT339901B publication Critical patent/AT339901B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/16Dicarboxylic acids and dihydroxy compounds
    • C08G63/18Dicarboxylic acids and dihydroxy compounds the acids or hydroxy compounds containing carbocyclic rings
    • C08G63/19Hydroxy compounds containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT157174A 1971-09-01 1974-02-26 Verfahren zur herstellung von neuen tetrazolderivaten AT339901B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17710271A 1971-09-01 1971-09-01
US335586A US3883513A (en) 1971-09-01 1973-02-26 Tetrazoyl derivatives of naturally occurring prostaglandins
US501189A US3928391A (en) 1971-09-01 1974-08-27 Certain cyclopentafuran diols substituted by certain-3-hydroxyalkyl (or alkenyl) groups useful in the preparation of prostaglandin analogs

Publications (2)

Publication Number Publication Date
ATA157174A ATA157174A (de) 1977-03-15
AT339901B true AT339901B (de) 1977-11-10

Family

ID=27390778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT157174A AT339901B (de) 1971-09-01 1974-02-26 Verfahren zur herstellung von neuen tetrazolderivaten

Country Status (10)

Country Link
US (2) US3883513A (de)
JP (1) JPS5029564A (de)
AT (1) AT339901B (de)
BE (2) BE811556A (de)
CA (1) CA1030150A (de)
CH (5) CH558386A (de)
DE (2) DE2242239C2 (de)
FR (2) FR2151053B1 (de)
GB (4) GB1373461A (de)
NL (2) NL173956C (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
US3980642A (en) * 1972-07-13 1976-09-14 Pfizer Inc. 15-Substitute D-ω-pentanorprostaglandins
US4113723A (en) * 1972-07-13 1978-09-12 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
US3962312A (en) * 1972-09-21 1976-06-08 Ono Pharmaceutical Company 9,11,15-Trihydroxy prost-5-enoic acid analogues
US4024179A (en) * 1972-11-08 1977-05-17 Pfizer Inc. Substituted ω-pentanorprostaglandins
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
DE2559093C3 (de) * 1975-12-30 1981-12-24 Pfizer Inc., 10017 New York, N.Y. 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere
US4043339A (en) * 1976-02-02 1977-08-23 The Upjohn Company Method of and vaginal insert for prostaglandin administration
US4410695A (en) * 1976-02-04 1983-10-18 The Upjohn Company 2-Decarboxy-2-tetrazolyl-6-keto-PG compounds
US4091207A (en) * 1976-04-22 1978-05-23 Pfizer Inc. Prostaglandin intermediate including oxathio heterocyclic ring
US4092349A (en) * 1976-11-10 1978-05-30 Pfizer Inc. 11-Desoxy-15-thiaprostaglandins
US4366313A (en) * 1977-09-02 1982-12-28 The Upjohn Company 2-Decarboxy-2-tetrazolyl-6-keto-PGE1 compounds
US4148804A (en) * 1978-01-11 1979-04-10 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl) 11-desoxy-15-thiaprostaglandins
DK523378A (da) * 1978-01-16 1979-07-17 Pfizer Fremgangsmaade til fremstilling af n-(tetrazol-5-yl) prostaglandin-carboxamider eller salte deraf
US4497827A (en) * 1982-08-30 1985-02-05 Syntex (U.S.A.) Inc. Arachidonic acid analogues as anti-inflammatory and anti-allergic agents
GB8511895D0 (en) * 1985-05-10 1985-06-19 Ici Plc Heterocyclic compounds
JPH0656079B2 (ja) * 1987-10-09 1994-07-27 株式会社熊谷組 水中への構造物の設置方法
US6323190B1 (en) * 1998-07-31 2001-11-27 The Univeristy Of Georgia Research Foundation, Inc. Estrogen mimetics lacking reproductive tract effects
RU2509768C2 (ru) 2008-09-10 2014-03-20 Асахи Гласс Компани, Лимитед Новое производное простагландина i2
HUE030206T2 (en) 2010-03-08 2017-04-28 Kaken Pharma Co Ltd New EP4 Agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711515A (en) * 1970-11-27 1973-01-16 Upjohn Co Tricyclic lactone alkene or alkenyne
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles

Also Published As

Publication number Publication date
FR2270252B2 (de) 1979-05-18
FR2151053A1 (de) 1973-04-13
CH553795A (fr) 1974-09-13
DE2409601A1 (de) 1974-09-12
CH572048A5 (de) 1976-01-30
NL173956B (nl) 1983-11-01
ATA157174A (de) 1977-03-15
CH561204A5 (de) 1975-04-30
BE788209A (fr) 1973-02-28
FR2270252A2 (de) 1975-12-05
GB1373462A (en) 1974-11-13
NL173956C (nl) 1983-11-01
GB1373463A (en) 1974-11-13
DE2242239A1 (de) 1973-03-22
CH566332A5 (de) 1975-09-15
US3928391A (en) 1975-12-23
CH558386A (fr) 1975-01-31
JPS5029564A (de) 1975-03-25
NL7402606A (de) 1974-08-28
AU4594672A (en) 1974-02-28
DE2242239C2 (de) 1981-12-03
GB1373461A (en) 1974-11-13
NL7211860A (de) 1973-03-05
BE811556A (fr) 1974-08-26
CA1030150A (en) 1978-04-25
FR2151053B1 (de) 1978-07-28
US3883513A (en) 1975-05-13
GB1458266A (en) 1976-12-15
AU6592974A (en) 1975-08-28

Similar Documents

Publication Publication Date Title
AT321923B (de) Verfahren zur herstellung von neuen imidazotriazinonen
AT323170B (de) Verfahren zur herstellung von neuen pyridinderivaten
AT327887B (de) Verfahren zur herstellung von neuen imidazolderivaten
AT339901B (de) Verfahren zur herstellung von neuen tetrazolderivaten
ATA779373A (de) Verfahren zur herstellung von neuen a-phenylindolderivaten
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT331808B (de) Verfahren zur herstellung von neuen 1-nitrosoharnstoffderivaten
AT327407B (de) Verfahren zur herstellung von neuen benzomorphanderivaten
AT326145B (de) Verfahren zur herstellung von neuen phosphonoureidoverbindungen
AT335424B (de) Verfahren zur herstellung von neuen phenyl-benzyl-ketonen
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT325202B (de) Verfahren zur herstellung von neuen halogenphenylthioacetamidocephalosporinderivaten
AT322103B (de) Verfahren zur herstellung von neuen penicillinderivaten
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
AT329565B (de) Verfahren zur herstellung von neuen chinazolinderivaten
ATA851577A (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
ATA258672A (de) Verfahren zur herstellung von neuen 17alfa-athinylostriolderivaten
ATA10875A (de) Verfahren zur herstellung von neuen chinazolinderivaten
AT339513B (de) Verfahren zur herstellung von neuen pregnansaure-derivaten
AT327199B (de) Verfahren zur herstellung von neuen nitrochinazolinonen
AT323903B (de) Verfahren zur herstellung von neuen alfa-l-talomethylosiden
AT327205B (de) Verfahren zur herstellung von neuen nitrochinazolinonen
ATA589575A (de) Verfahren zur herstellung von neuen phenyl-benzyl-ketonen
AT334914B (de) Verfahren zur herstellung von neuen tetrasila-adamantan-verbindungen
AT323906B (de) Verfahren zur herstellung von neuen östratrienen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee